These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6163937)

  • 21. [Pancreatic ascites (author's transl)].
    Altuğ K; Bekem S; Yağci M; Akçakil M; Budak D
    Zentralbl Chir; 1976; 101(22):1376-8. PubMed ID: 1014979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
    Gasko R; Klímová N
    Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
    Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
    Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and ascitic fluid lactic dehydrogenase in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK; el-Sawy M
    J Trop Med Hyg; 1970 Oct; 73(10):240-4. PubMed ID: 5478039
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pancreatogenic ascites].
    Satz N; Ammann R
    Schweiz Med Wochenschr; 1978 Jul; 108(26):980-8. PubMed ID: 663590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lactic acid in the ascitic fluid of patients with liver cirrhosis].
    Obrador Adrover A; Altés Capellà J; Muret Mayoral R; Fortesa-Rei Borralleras J; Gayà Cantallops J
    Med Clin (Barc); 1984 Jun; 83(3):97-100. PubMed ID: 6482561
    [No Abstract]   [Full Text] [Related]  

  • 28. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing between malignant and cirrhotic ascites by computerized step-wise discriminant functional analysis of its biochemistry.
    Greene LS; Levine R; Gross MJ; Gordon S
    Am J Gastroenterol; 1978 Nov; 70(5):448-54. PubMed ID: 742603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
    Paré P; Talbot J; Hoefs JC
    Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascitic fluid to serum bilirubin concentration ratio for the classification of transudates or exudates.
    Elis A; Meisel S; Tishler T; Kitai Y; Lishner M
    Am J Gastroenterol; 1998 Mar; 93(3):401-3. PubMed ID: 9517648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of the biochemical profile (total protein, cholesterol, glucose, mucoprotein and amylase) of ascitic fluid].
    Polak M; da Costa AC; Bitelman B; Faria RM; Miranda CR; Bettarello E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Aug; 33(4):186-99. PubMed ID: 725419
    [No Abstract]   [Full Text] [Related]  

  • 33. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic ascites.
    Dhawan P; Amarapurkar DN; Bhandarkar P; Kalro RH
    J Assoc Physicians India; 1993 Sep; 41(9):582-3. PubMed ID: 7508432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemopexin and immunoglobulins in benign and malignant ascites. Experience in 66 patients].
    Valicenti PA; Torino ML; Osatinsky R; Huberman ED
    Acta Gastroenterol Latinoam; 1986; 16(2):81-92. PubMed ID: 3577623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
    Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
    Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chylous ascites in cirrhotic and non-cirrhotic patients].
    Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
    Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of amylase determination in ascites].
    Polak M; Torres da Costa AC
    Z Gastroenterol; 1972 Nov; 10(7):561-6. PubMed ID: 4657036
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tumor markers and immunomodulator substances in ascites--their value as screening and diagnosis parameters].
    Satz N; Joller-Jemelka HI; Grob PJ; Hofer C; Schmid E; Knoblauch M
    Schweiz Med Wochenschr; 1989 May; 119(21):762-5. PubMed ID: 2474198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal fluid adipokines: ready for prime time?
    Wiest R; Leidl F; Kopp A; Weigert J; Neumeier M; Buechler C; Schoelmerich J; Schäffler A
    Eur J Clin Invest; 2009 Mar; 39(3):219-29. PubMed ID: 19260952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.